Biocon Limited

NSEI:BIOCON Rapporto sulle azioni

Cap. di mercato: ₹424.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Biocon Gestione

Gestione criteri di controllo 3/4

Biocon's Il CEO è Siddharth Mittal, nominato in Dec2019, e ha un mandato di 4.67 anni. la retribuzione annua totale è ₹ 57.31M, composta da 100% di stipendio e 0% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.069% delle azioni della società, per un valore di ₹ 286.43M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2 anni e 2.8 anni.

Informazioni chiave

Siddharth Mittal

Amministratore delegato

₹57.3m

Compenso totale

Percentuale dello stipendio del CEO100.0%
Mandato del CEO4.7yrs
Proprietà del CEO0.07%
Durata media del management2yrs
Durata media del Consiglio di amministrazione2.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Jun 29
Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Is Biocon (NSE:BIOCON) A Risky Investment?

Jun 11
Is Biocon (NSE:BIOCON) A Risky Investment?

Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Jun 11
Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

May 24
Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

May 23
Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Mar 20
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Feb 12
Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Jan 23
Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

Jan 03
Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Nov 13
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Aug 03
Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Jul 03
Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 02
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

May 26
Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Mar 28
Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Feb 26
Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Dec 17
Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Sep 05
Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 13
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

May 26
Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Mar 28
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Siddharth Mittal rispetto agli utili di Biocon?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

₹16b

Mar 31 2024₹57m₹57m

₹10b

Dec 31 2023n/an/a

₹12b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹48m₹48m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹6b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹42m₹42m

₹6b

Dec 31 2021n/an/a

₹7b

Sep 30 2021n/an/a

₹7b

Jun 30 2021n/an/a

₹7b

Mar 31 2021₹43m₹43m

₹7b

Dec 31 2020n/an/a

₹6b

Sep 30 2020n/an/a

₹6b

Jun 30 2020n/an/a

₹7b

Mar 31 2020₹49m₹31m

₹8b

Compensazione vs Mercato: La retribuzione totale di Siddharth ($USD 683.36K ) è circa la media per le aziende di dimensioni simili nel mercato Indian ($USD 641.91K ).

Compensazione vs guadagni: La retribuzione di Siddharth è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Siddharth Mittal (46 yo)

4.7yrs

Mandato

₹57,310,000

Compensazione

Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Kiran Mazumdar-Shaw
Founder & Executive Chairperson45.8yrs₹38.43m40.49%
₹ 172.0b
Siddharth Mittal
MD, CEO & Director4.7yrs₹57.31m0.069%
₹ 294.9m
Peter James Bains
Group Chief Executive Officerless than a year₹1.91mNessun dato
Mukesh Kamath
Chief Financial Officerless than a yearNessun datoNessun dato
Arun Gupta
Head of Operations1.3yrsNessun datoNessun dato
Atanu Roy
Group Chief Information Officer3.9yrsNessun datoNessun dato
Saurabh Paliwal
Head of Investor Relations2yrsNessun datoNessun dato
Mayank Verma
Company Secretary & Compliance Officer5.1yrs₹5.75mNessun dato
Seema Ahuja
Global Head of Communications & Corporate Brandno dataNessun datoNessun dato
Maninder Puri
Head of Human Resourcesno dataNessun datoNessun dato
Paul Thomas
Chief Commercial Officerno dataNessun datoNessun dato
Abhijit Zutshi
Commercial Head of Biocon Global Genericsno dataNessun dato0.019%
₹ 78.9m

2.0yrs

Durata media

54.5yo

Età media

Gestione esperta: Il team dirigenziale di BIOCON è considerato esperto (durata media dell'incarico 2 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Kiran Mazumdar-Shaw
Founder & Executive Chairperson45.8yrs₹38.43m40.49%
₹ 172.0b
Siddharth Mittal
MD, CEO & Director4.7yrs₹57.31m0.069%
₹ 294.9m
Ravi Mazumdar
Non-Executive Non-Independent Director24yrs₹6.23m0.44%
₹ 1.9b
Bobby Parikh
Independent Non-Executive Director6.1yrs₹7.81mNessun dato
Naina Lal Kidwai
Additional Non-Executive Independent Director2.3yrs₹6.24mNessun dato
Satish Garg
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Nicholas Haggar
Independent Directorless than a year₹5.20mNessun dato
Shashank Joshi
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Rekha Menon
Independent Director1.1yrs₹5.70mNessun dato
Eric Mazumdar
Non-Executive Director2.8yrs₹5.57m0.27%
₹ 1.1b
John Petrie
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Atul Dhawan
Non-Executive and Independent Directorless than a yearNessun datoNessun dato

2.8yrs

Durata media

62.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di BIOCON non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.